{"Title":"Co-Diagnostics","Industry":"SURGICAL \u0026 MEDICAL INSTRUMENTS \u0026 APPARATUS","Employees":"12","Founded":"","Address":"","Phone":"(801) 278-9769","Web_address":"http://www.codiagnostics.com","Market_cup":"$59.3mil","Revenues":"$0 mil (last 12 months)","Net_income":"$-2.1 mil (last 12 months)","Symbol":"CODX","Exchange":"NASDAQ","Shares":"1.2","Price_range":"$6.00 - $6.00","Est_volume":"$7.1 mil","Manager":"WallachBeth Capital/ Network 1 Securities","CO_managers":"-","Exp_to_trade":"7/12/2017","Status":"","Quiet_period":"Available only to Subscribers","Lock_up_period":"Available only to Subscribers","Scoop_rate":"Available only to Subscribers","Rating_change":"Available only to Subscribers","Business":"Co-Diagnostics, Inc. (“Company,” or “CDI,”), a Utah corporation, is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems (which we refer to as the “MDx device”) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA)."}